+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Animal Vaccines Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

  • ID: 5144131
  • Report
  • August 2020
  • Region: Global
  • 110 pages
  • Zion Market Research
According to the report, global demand for Animal Vaccines market was valued at approximately USD 10.2 billion in 2019, and is expected to generate revenue of around USD 15.5 billion by end of 2026, growing at a CAGR of around 6.1 % between 2020 and 2026.

Vaccination has been one of the most important conciliations in disease prevention that has ever been developed.The effectiveness of vaccination is seen by the reduction in disease.Animal vaccines provide protection against various diseases such as rabies, feline panleukopenia, feline viral rhinotracheitis, feline calicivirus infection, canine distemper, canine parvovirus infection, and canine hepatitis. Hence, most of the animal doctors recommend vaccines depending on the type and severity of the disease.

Animal vaccines can be made available without large, controlled dispute studies that are mandatory prior to the release of human vaccines. Animal vaccines are controlled by the US Department of Agriculture, which hardly requires the vaccines to be shown to be safe and pure, and have a “reasonable expectation” of efficacy prior to their release.Nevertheless, the clinical relevancy or applicability of a particular vaccine may not necessarily be assured by the licensing process. This fact makes it easier for the manufacturers to provide animal vaccines and meet the rising demand in the global market.

Based on the type of vaccine, the global animal vaccines market is segmented as inactivated vaccines, toxoid vaccines, live attenuated vaccines, subunit vaccines, and others. The others segment is further sub-segmented as conjugate vaccines, recombinant vaccines, and DNA vaccines. Of which, the DNA vaccines segment is anticipated to account for the highest growth in the near future. On the basis of disease category, the global market is segmented as anthrax vaccines, rabies vaccine, brucellosis vaccine, DA2PPC vaccine, clostridium vaccine, and others. Based on the product type, the market is further segmented as companion animal, porcine, livestock, equine, poultry, aquaculture, and other animal vaccines. Owing to the rising number of pet owners worldwide, the companion animal segment proves to be largest and the fastest growing segment in the global market.

The growth of global animal vaccines market is expected to boost owing to the increase in the livestock population and frequent occurrence of livestock diseases. In addition, factors such as rising prevalence of zoonotic diseases, various initiatives were taken up by different government agencies and animal associations, and the introduction of new vaccine types also impact the growth of the market in a positive way. Moreover, technological innovations, growing awareness regarding animal health in the emerging countries, etc. are some other factors boosting the market growth.

Asia Pacific is experiencing the highest growth in the global market owing to its increased consumption and trade of meat. This trend is followed by China due to its rising consumption of meat. The global animal vaccines market is dominated by North Americafollowed by Europe and Asia-Pacific.

Major players of the animal vaccines market include Merck Animal Health, Bayer Healthcare Novartis, Bimeda Inc., Ceva Sante Animale, Eli Lilly and Company, and Zoetis. Other key players who dominate the market are Sanofi-Aventis, Boehringer Ingelheim GmbH, and Virbac Inc.

Animal VaccinesMarket: Regional Segment Analysis
  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Animal Vaccines Market, 2016 - 2026, (USD Million)
    • 2.2. Animal Vaccines Market: Snapshot
  • Chapter 3. Global Animal Vaccines Market – Industry Analysis
    • 3.1. Animal Vaccines Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increase in the livestock population and frequent occurrence of livestock diseases
      • 3.2.2. Rising prevalence of zoonotic diseases
    • 3.3. Restraints
      • 3.3.1. High Cost
    • 3.4. Opportunity
      • 3.4.1. Technulogical innovations, growing awareness regarding animal health in the emerging countries
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Type of vaccine segment
      • 3.6.2. Market attractiveness analysis by Disease category segment
      • 3.6.3. Market attractiveness analysis by Product Type segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Animal Vaccines Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Animal Vaccines market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Disease category launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Animal Vaccines Market – Disease category Segment Analysis
    • 5.1. Global Animal Vaccines market overview: by Type of vaccine
      • 5.1.1. Global Animal Vaccines market revenue share, by Type of vaccine, 2019 and 2026
    • 5.2. Inactivated vaccines
      • 5.2.1. Global Animal Vaccines market by Inactivated vaccines, 2016-2026 (USD Million)
    • 5.3. Toxoid vaccines
      • 5.3.1. Global Animal Vaccines market by Toxoid vaccines, 2016-2026 (USD Million)
    • 5.4. Live attenuated vaccines
      • 5.4.1. Global Animal Vaccines market by Live attenuated vaccines, 2016-2026 (USD Million)
    • 5.5. Subunit vaccines
      • 5.5.1. Global Animal Vaccines market by Subunit vaccines, 2016-2026 (USD Million)
    • 5.6. Others
      • 5.6.1. Global Animal Vaccines market by Others, 2016-2026 (USD Million)
  • Chapter 6. Global Animal Vaccines Market – Disease category Segment Analysis
    • 6.1. Global Animal Vaccines market overview: by Disease category
      • 6.1.1. Global Animal Vaccines market revenue share, by Disease category, 2019 and 2026
    • 6.2. Anthrax vaccines
      • 6.2.1. Global Animal Vaccines market by Anthrax vaccines, 2016-2026 (USD Million)
    • 6.3. Rabies vaccine
      • 6.3.1. Global Animal Vaccines market by Rabies vaccine, 2016-2026 (USD Million)
    • 6.4. Brucellosis vaccine
      • 6.4.1. Global Animal Vaccines market by Brucellosis vaccine, 2016-2026 (USD Million)
    • 6.5. Da2ppc Vaccine
      • 6.5.1. Global Animal Vaccines market by Da2ppc Vaccine, 2016-2026 (USD Million)
    • 6.6. Clostridium vaccine
      • 6.6.1. Global Animal Vaccines market by Clostridium vaccine, 2016-2026 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Animal Vaccines market by Others, 2016-2026 (USD Million)
  • Chapter 7. Global Animal Vaccines Market – Product Type Segment Analysis
    • 7.1. Global Animal Vaccines market overview: by Product Type
      • 7.1.1. Global Animal Vaccines market revenue share, by Product Type, 2019 and 2026
    • 7.2. Companion animal
      • 7.2.1. Global Animal Vaccines market by Companion animal, 2016-2026 (USD Million)
    • 7.3. Porcine
      • 7.3.1. Global Animal Vaccines market by Porcine, 2016-2026 (USD Million)
    • 7.4. Livestock
      • 7.4.1. Global Animal Vaccines market by Livestock, 2016-2026 (USD Million)
    • 7.5. Equine
      • 7.5.1. Global Animal Vaccines market by Equine, 2016-2026 (USD Million)
    • 7.6. Poultry
      • 7.6.1. Global Animal Vaccines market by Poultry, 2016-2026 (USD Million)
    • 7.7. Aquaculture
      • 7.7.1. Global Animal Vaccines market by Aquaculture, 2016-2026 (USD Million)
    • 7.8. Other animal vaccines
      • 7.8.1. Global Animal Vaccines market by Other animal vaccines, 2016-2026 (USD Million)
  • Chapter 8. Global Animal Vaccines Market - Regional Analysis
    • 8.1. Global Animal Vaccines market overview: by region
      • 8.1.1. Global Animal Vaccines market revenue share, by region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America Animal Vaccines market, by country, 2016-2026 (USD Million)
      • 8.2.2. North America Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
      • 8.2.3. North America Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
      • 8.2.4. North America Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.2.5.2. The U.S. Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.2.5.3. The U.S. Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.2.6.2. Rest of North America Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.2.6.3. Rest of North America Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Animal Vaccines market, by country, 2016-2026 (USD Million)
      • 8.3.2. Europe Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
      • 8.3.3. Europe Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
      • 8.3.4. Europe Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.3.5.2. U.K. Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.3.5.3. U.K. Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.3.6.2. France Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.3.6.3. France Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.3.7.2. Germany Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.3.7.3. Germany Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.3.8.2. Rest of Europe Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.3.8.3. Rest of Europe Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Animal Vaccines market, by country, 2016-2026 (USD Million)
      • 8.4.2. Asia Pacific Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
      • 8.4.3. Asia Pacific Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
      • 8.4.4. Asia Pacific Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.4.5.2. China Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.4.5.3. China Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.4.6.2. Japan Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.4.6.3. Japan Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.4.7.2. India Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.4.7.3. India Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Animal Vaccines market, by country, 2016-2026 (USD Million)
      • 8.5.2. Latin America Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
      • 8.5.3. Latin America Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
      • 8.5.4. Latin America Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.5.5.2. Brazil Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.5.5.3. Brazil Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
        • 8.5.6.2. Rest of Latin America Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
        • 8.5.6.3. Rest of Latin America Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Animal Vaccines market, 2016-2026 (USD Million)
      • 8.6.2. Middle East & Africa Animal Vaccines market revenue, by Type of vaccine, 2016-2026 (USD Million)
      • 8.6.3. Middle East & Africa Animal Vaccines market revenue, by Disease category, 2016-2026 (USD Million)
      • 8.6.4. Middle East & Africa Animal Vaccines market revenue, by Product Type, 2016-2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Merck Animal Health.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Bayer Healthcare
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Novartis
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Bimeda Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Ceva Sante Animale
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Eli Lilly and Company
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Zoetis
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Sanofi-Aventis,
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Boehringer Ingelheim GmbH.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Virbac Inc
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments
Note: Product cover images may vary from those shown
Adroll
adroll